Women With Mental Disorders And Mammograms

Women With Mental Disorders And Mammograms
Women with mental disorders are less likely to have screening mammograms than women without mental illness, although. the nature of the mental illness does play a role, as per a large study published by Indiana University School of Medicine and Richard Roudebush VA Health Services Center for Excellence scientists in the recent issue of Journal of General Internal Medicine. Previous to this study, little was known about whether the type or severity of mental illness influences receipt of preventive services such as mammograms........
Source: medicineworld.org

Hoodia Weight Loss Patch: Does it Work?
Hoodia Weight Loss Patch: Does it Work?
Source: hoodiaweightlosssite.com\_

"View our Spring Special Promotions" >>>

Source: page2rss.com

Psychological Needs Of Breast Cancer Patients
Almost half of newly diagnosed patients with breast cancer are found to have clinically significant emotional distress or symptoms of psychiatric disorders before therapy is begun, as per a new study reported in the recent issue of CANCER, a peer-evaluated journal of the American Cancer Society. The study reveals that while virtually all of the women admitted to, experiencing some level of emotional distress, 47 percent met clinically significant screening criteria for emotional distress or a psychiatric disorder, including major depression and post-traumatic stress disorder (PTSD)........
Source: medicineworld.org

A leading UK medical cosmetic doctor is very impressed by Biodental

Source: page2rss.com

Facts About The Hoodia Gordonii Plant
Facts About The Hoodia Gordonii Plant
Source: hoodiaweightlosssite.com\_

Read a Hoodia Patch Review: See What People Have to Say
Read a Hoodia Patch Review: See What People Have to Say
Source: hoodiaweightlosssite.com\_

Gene profiling and resistance to Herceptin
Using gene chips to profile tumors before therapy, scientists at Harvard and Yale Universities found markers that identified breast cancer subtypes resistant to Herceptin, the primary therapy for HER2-positive breast cancer. They say this advance could help further refine treatment for the 25 to 30 percent of patients with breast cancer with this class of tumor........
Source: medicineworld.org